Commonwealth Equity Services’s Medicus Pharma MDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.9K Buy
1,477
+424
+40% +$5.89K ﹤0.01% 4358
2026
Q2
$23.5K Buy
1,053
+90
+9% +$1.59K ﹤0.01% 4352
2026
Q1
$22.1K Buy
963
+393
+69% +$20.5K ﹤0.01% 4249
2025
Q4
$43.6K Buy
570
+352
+161% +$37.7K ﹤0.01% 4195
2025
Q3
$25K Buy
+218
New +$27.3K ﹤0.01% 4200

Other funds holding MDCX

Commonwealth Equity Services's MDCX Position: Q3 2026 in Review

Commonwealth Equity Services increased its Medicus Pharma (MDCX) stake by 40% in Q3 2026, buying an estimated $5.89K and bringing the position to 1,477 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4358.

Commonwealth Equity Services first reported a position in MDCX in Q3 2025 and has held it in 5 quarters since. The position peaked at $43.6K in Q4 2025. 5 funds tracked by Wall St. Rank hold MDCX as of Q3 2026.

  • Commonwealth Equity Services held 1,477 shares of Medicus Pharma worth $11.9K as of Q3 2026.
  • Commonwealth Equity Services bought 424 Medicus Pharma shares in Q3 2026, an estimated $5.89K.
  • Medicus Pharma made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #4358 holding.
  • Commonwealth Equity Services first reported a position in Medicus Pharma in Q3 2025 and has held it in 5 quarters since.
  • Commonwealth Equity Services's Medicus Pharma position peaked at $43.6K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.